Navigation Links
Aureus Pharma Releases New Unified Knowledge Database
Date:8/18/2008

21st.

About Aureus Pharma

Aureus Pharma headquartered in Paris, France is a privately held

knowledge management based solutions provider for the life sciences

industry. Aureus Pharma accelerates new drug discovery by providing

knowledge databases which contain high quality quantitative information

for both chemistry and biology. Researchers gain rapid access to

knowledge for important drug target classes as well as ADME/Tox topics.

The information contained in the Aureus Pharma system is of primary

importance to aid in lead discovery and optimization as well as to

build predictive models. For further information on how Aureus Pharma

helps researchers turn data into discovery visit

http://www.aureus-pharma.com

Media Contact

Mary E. Donlan, Ph.D.

Director of Marketing

Aureus Pharma

Phone:+33-1-40-18-57-59 / +33-6-76-19-51-77

mary.donlan@aureus-pharma.com


'/>"/>
SOURCE Aureus Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution
2. Aureus Pharma Announces Date of 2008 Annual User Symposium
3. QSB Anti-Virulence Platform Inhibits Biofilm Formation by Staphylococcus Aureus MRSA and Candida sp
4. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
5. New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus (MRSA)
6. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
7. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
8. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
9. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
10. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
11. Ondine Biopharma Announces Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 Local veterinarian, Dr. ... Hospital are seeking candidates to participate in an investigational ... The ultimate goal of this study is to ... into one or two arthritically affected joints can help ... , Candidates for the current investigational study must be ...
(Date:8/29/2014)... 29, 2014 Intrinsic Imaging, an ... GAMP® 5 compliant imaging core lab, announced today ... II clinical trial to assess a new treatment ... trial, Intrinsic Imaging will provide comprehensive imaging core ... and charter development, site qualification, site training and ...
(Date:8/28/2014)... 2014 “This kit has an improved extraction ... 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin Product ... to plant owners and USDA-GIPSA inspection agencies that have a ... can take place in a matter of minutes with nothing ... test the feed and grain before accepting it, but they ...
(Date:8/28/2014)... PA (PRWEB) August 28, 2014 The ... create a culture that will allow individuals to perform ... becoming increasingly important for employers looking to compete in ... industries are embracing this trend, as the sector increasingly ... of a company, which will have real results on ...
Breaking Biology Technology:Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3
... Calif., Feb. 4 NeurogesX, Inc. (Nasdaq: ... commercializing novel pain management therapies, announced today that Anthony ... present at the 11th Annual BIO CEO & Investor ... 2009. Mr. DiTonno and Stephen Ghiglieri, Chief Financial Officer, ...
... Texcel,s custom medical device development and manufacturing ... the commercialization of their surgical, interventional, and implantable ... full array of services and technologies at the ... booth # 314.Texcel provides the manufacturing infrastructure and ...
... Art,s Way Manufacturing, Inc. (Nasdaq: ARTW ... Scientific, Inc. - Buildings For Science - has ... The new site, reflective of the company,s ... more user-friendly.Art,s Way Scientific ( http://www.buildingsforscience.com ) is ...
Cached Biology Technology:NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 2NeurogesX to Present at 11th Annual BIO CEO & Investor Conference 3Texcel Highlights Medical Device Development & Manufacturing Solutions at MD&M West, booth 314 2Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 2Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 3
(Date:8/28/2014)... A unique method for delivering compounds that ... HIV and AIDS may be possible, thanks ... Agricultural Sciences., A semi-soft vaginal suppository made ... loaded with the antiviral drug Tenofovir provides ... against the spread of sexually transmitted infections ...
(Date:8/28/2014)... new roads will be built worldwide by 2050. Many ... where they bring an influx of destructive loggers, hunters ... has created a ,global roadmap, for prioritising road building ... demands of development and environmental protection. , The map ... natural importance of ecosystems and a ,road-benefits, layer that ...
(Date:8/28/2014)... more action is needed to ensure safeguards are in ... in PLOS ONE , researchers from Monash University, ... - combining results from different studies - to look ... areas, to determine whether they actually protect biodiversity. ... protecting an area from human exploitation made common sense, ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3Protected areas proven to protect biodiversity 2
... 26 October 2008 Arpida (SWX: ARPN) today ... III clinical trials at the 48th Interscience Conference ... of America (IDSA) 46th annual meeting in Washington, ... antibiotic, showed high clinical cure rates which were ...
... 2008 -- The Soil Science Society of America (SSSA) recognized ... special Awards Ceremony during their Annual Meeting on Oct. 5-9 ... colleagues based on their professional achievements and meritorious service. Only ... be elected Fellow. The 2008 class of SSSA Fellows are: ...
... Berlin, Germany Current research suggests that stress may ... skin disease. The related report by Joachim et ... Cells towards Maturation and Migration: Key role of ICAM-1/LFA-1 ... American Journal of Pathology . Skin provides the ...
Cached Biology News:Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections 2Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections 3Soil Science Society of America presents 2008 fellows 2Soil Science Society of America presents 2008 fellows 3Soil Science Society of America presents 2008 fellows 4Soil Science Society of America presents 2008 fellows 5Stress may make you itch 2
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
D-biotin *50 mM aqueous solution* Secondary Detection Biotin–Avidin Detection Reagents Other...
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: